模块化锥形柄治疗Vancouver B2/B3假体周围骨折:平均7.8年生存率与影像学结果
回顾性纳入46例Vancouver B2/B3股骨假体周围骨折行翻修全髋关节置换术并使用模块化锥形股骨柄的患者,平均随访7.6年。15年全因失败生存率为95.1%(95%CI 88.7-100.0),总体并发症率13.0%,翻修率4.3%,末次随访95.2%患者可行走。结论认为该方案是可行治疗选择,提供优异的10-15年生存率和影像学结果,并发症率低。
要点
- 模块化锥形柄翻修THA治疗Vancouver B2/B3假体周围骨折15年全因失败生存率95.1%。
- 总体并发症率13.0%,包括脱位4例、感染1例、髂腰肌腱炎1例。
- 总体翻修率4.3%,末次随访95.2%患者可行走。
核心结论
- 模块化锥形股骨柄翻修全髋关节置换术治疗Vancouver B2和B3股骨假体周围骨折是可行治疗选择,提供优异的10至15年生存率和影像学结果,并发症率低。
研究设计与样本
- 46例中女性30例(65.2%),手术时平均年龄73岁(范围33至93),平均随访7.6年(范围2.0至22.6)。
- 67.4%(31/46)患者分类为Vancouver B2骨折,采用Kaplan-Meier生存分析,失败定义为任何原因翻修手术。
主要发现
- 15年全因失败Kaplan-Meier生存率为95.1%(95%CI 88.7-100.0),有4髋处于风险。
- 总体并发症率13.0%(6/46),包括脱位4例、感染1例、髂腰肌腱炎1例。
- 总体翻修率4.3%(2/46),翻修原因为脱位1例和感染1例。
- 末次随访95.2%(40/42)患者可行走。
关键数值与推荐
- 15年全因失败生存率95.1%(95%CI 88.7-100.0),有4髋处于风险。
- 总体并发症率13.0%(6/46),总体翻修率4.3%(2/46)。
- 末次随访95.2%(40/42)患者可行走。
临床怎么用
- 对于Vancouver B2和B3股骨假体周围骨折,可考虑使用模块化锥形股骨柄行翻修全髋关节置换术,其10至15年生存率优异且并发症率低。
- 术后需关注脱位、感染和髂腰肌腱炎等并发症,本研究中脱位是最常见并发症。
局限性
- 本研究为回顾性研究,样本量46例,部分时间点处于风险髋数较少(15年时仅4髋)。
- 未来需评估患者报告结局并在更大队列中进行更长随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Periprosthetic fractures (PPFs) of the femur are a frequent complication following total hip arthroplasty (THA). Revision THA using a modular tapered stem is a common treatment strategy for these fractures. The purpose of this study was to report the survivorship and clinical outcomes of revision THA using a modular tapered femoral stem to treat PPF of the femur. METHODS: A total of 46 patients were included from our retrospective review of revision THAs performed for Vancouver B2 and B3 fractures between January 2001 and December 2022. A minimum follow-up of two years was required. Among these patients, 30 (65.2%) were women, the mean age at the time of surgery was 73 years (range, 33 to 93), and the mean follow-up was 7.6 years (range, 2.0 to 22.6). Overall, 67.4% (31 of 46) patients were classified as Vancouver B2 fractures. Kaplan-Meier survivorship analysis was conducted with failure defined as revision surgery for any reason. RESULTS: Kaplan-Meier survivorship due to all-cause failure for patients who underwent revision THA to treat PPF via a modular tapered stem was 95.1% (95% confidence interval: 88.7 to 100.0) at 15 years with four hips at risk. The overall complication rate was 13.0% (6 of 46), which included dislocation (4), infection (one), and iliopsoas tendonitis (one). The overall revision rate was 4.3% (two of 46), with revisions performed for dislocation (one) and infection (one). Overall, 95.2% (40 of 42) of patients were ambulatory at final follow-up. CONCLUSIONS: Our study suggests revision THA using a modular tapered femoral stem for Vancouver B2 and B3 PPF of the femur is a viable treatment option, providing excellent 10- to 15-year survivorship and radiographic outcomes with a low complication rate. Future research should evaluate patient-reported outcomes and longer-term follow-up in larger cohorts.
引用
- Chaudhry F, Bridger A, Kolhatkar K, et al. Treatment of Vancouver B2 and B3 Periprosthetic Femoral Fractures Using a Modular Tapered Stem: Survivorship and Radiographic Outcomes at Mean 7.8-Year Follow-Up. J Arthroplasty. 2026. PMID: 42843686. doi:10.1016/j.arth.2026.09.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。